Literature DB >> 19142995

Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?

Oussama Abla1, Sheila Weitzman, Milen Minkov, Kenneth L McClain, Johannes Visser, Alexandra Filipovich, Nicole Grois.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19142995     DOI： 10.1002/pbc.21924

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  4 in total

1.  Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.

Authors:  Yoko Shioda; Souichi Adachi; Shinsaku Imashuku; Kazuko Kudo; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

2.  Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis.

Authors:  Shinsaku Imashuku; Naoko Kudo; Shigehiro Kaneda; Hiroshi Kuroda; Tsuguka Shiwa; Tetsuya Hiraiwa; Atsushi Inagaki; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

3.  [Unusual presentation of a Langerhans cell histiocytosis].

Authors:  R Bergholz; E Bertelmann; P Hundsdoerfer; A Mußler; K Hauptmann; J Schroeter
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

Review 4.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.